Gastrointestinal onkoloji alan\u0131nda en zorlu kal\u0131tsal hastal\u0131klardan biri olarak kabul edilen Familial Adenomatous Polyposis (FAP), erken ya\u015fta kal\u0131n ba\u011f\u0131rsakta y\u00fczlerce hatta binlerce polip olu\u015fumuyla karakterize bir tablo sergilemektedir. Bu hastal\u0131\u011f\u0131n en kritik risk unsurlar\u0131 aras\u0131nda kolon kanseri geli\u015fimi yer al\u0131rken, son d\u00f6nemlerde yap\u0131lan ara\u015ft\u0131rmalar, duodenumda da kanser geli\u015fme riskinin olduk\u00e7a y\u00fcksek oldu\u011funu ortaya koymaktad\u0131r. Ancak, \u015fu ana kadar duodenal kanser riski, \u00e7o\u011funlukla endoskopik tarama ve polipektomi gibi invazif y\u00f6ntemlerle kontrol alt\u0131nda tutulmaya \u00e7al\u0131\u015f\u0131lm\u0131\u015f olup, bu alanda \u00f6zelle\u015ftirilmi\u015f ve etkili \u00f6nleyici tedavi se\u00e7enekleri bulunmamaktad\u0131r. Almanya\u2019dan, Bonn \u00dcniversitesi Hastanesi (UKB) liderli\u011finde ger\u00e7ekle\u015ftirilen yeni \u00e7al\u0131\u015fmalar, FAP hastalar\u0131n\u0131n duodenal mukozas\u0131ndaki ba\u011f\u0131\u015f\u0131kl\u0131k mikro\u00e7evresinin karma\u015f\u0131k yap\u0131s\u0131n\u0131 anlamada \u00e7\u0131\u011f\u0131r a\u00e7an veriler sunmu\u015ftur.<\/p>\n
Bu ara\u015ft\u0131rman\u0131n merkezinde yer alan tip 3 do\u011fal lenfoid h\u00fccreler (ILC3), ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin hen\u00fcz tam olarak ayd\u0131nlat\u0131lamam\u0131\u015f ama \u00f6nemli bir alt k\u00fcmesi olarak dikkat \u00e7ekmektedir. FAP\u2019l\u0131 bireylerin duodenal mukozas\u0131nda, \u00f6zellikle displastik lezyonlar ve erken kanserle\u015fmi\u015f dokular \u00e7evresinde bu ILC3 h\u00fccrelerinin belirgin \u015fekilde birikmi\u015f oldu\u011fu saptanm\u0131\u015ft\u0131r. Bu art\u0131\u015f, sadece tesad\u00fcf\u00ee bir birikim olmay\u0131p, aktif mukozal transformasyon s\u00fcre\u00e7leriyle kuvvetli bir korelasyon g\u00f6stermektedir. Ara\u015ft\u0131rmac\u0131lar, burada tespit edilen NKp44 negatif fenotipe sahip, interl\u00f6kin-17A (IL-17A) \u00fcretimi yapan ILC3 h\u00fccrelerinin, iltihap, imm\u00fcn sinyalle\u015fme ve genomik instabilite aras\u0131nda \u00e7ok \u00f6nemli bir k\u00f6pr\u00fc i\u015flevini g\u00f6rebilece\u011fini ileri s\u00fcrm\u00fc\u015ft\u00fcr.<\/p>\n
IL-17A, klasik olarak otoimm\u00fcn hastal\u0131klar ve kronik inflamasyonla ili\u015fkili pro-inflamatuar bir sitokin olarak bilinmektedir. Bonn ekibinin molek\u00fcler analizlerinde, ILC3 kaynakl\u0131 IL-17A\u2019n\u0131n duodenal epitel h\u00fccrelerine reaktif oksijen t\u00fcrleri (ROS) \u00fcretimini art\u0131rma sinyali verdi\u011fi ortaya \u00e7\u0131km\u0131\u015ft\u0131r. ROS, h\u00fccre bile\u015fenlerine ve \u00f6zellikle DNA\u2019ya zarar veren kimyasal olarak reaktif molek\u00fcllerdir. Artan ROS seviyeleri DNA’da kopmalar, baz modifikasyonlar\u0131 ve kromozom instabilitesi gibi hasarlarla sonu\u00e7lanmaktad\u0131r. Bu t\u00fcr genetik hasarlar, onkojenik mutasyonlar\u0131n temelini olu\u015fturur. B\u00f6ylece IL-17A ve ROS aras\u0131ndaki patolojik d\u00f6ng\u00fc, FAP\u2019daki duodenal mukozada maligle\u015fme s\u00fcre\u00e7lerini h\u0131zland\u0131ran \u00f6nemli bir fakt\u00f6r olarak kar\u015f\u0131m\u0131za \u00e7\u0131kmaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rma ayr\u0131ca, FAP hastalar\u0131n\u0131n duodenal mukozas\u0131nda IL-17A salg\u0131layan ILC3\u2019lerin orant\u0131s\u0131z bir \u015fekilde \u00e7o\u011fald\u0131\u011f\u0131n\u0131 ve bu durumun genetik olarak neoplastik geli\u015fmeye yatk\u0131n dokuda iltihabi bir mikro\u00e7evre yaratarak genetik hasar\u0131 artt\u0131rd\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015ftir. Bu ba\u011f\u0131\u015f\u0131kl\u0131k nedenli mutajenik stresin \u00e7o\u011falmas\u0131, kanser geli\u015fim riskini sadece genetik yatk\u0131nl\u0131kla a\u00e7\u0131klamay\u0131 yetersiz b\u0131rakmaktad\u0131r. Art\u0131k ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin, malignitenin \u00f6nlenmesinde pasif ya da sadece koruyucu rol\u00fcn\u00fcn \u00f6tesinde, baz\u0131 imm\u00fcn alt pop\u00fclasyonlar\u0131n\u0131n k\u00f6t\u00fc niyetli t\u00fcm\u00f6r ba\u015flat\u0131c\u0131lar\u0131 olarak hareket edebilece\u011fi anla\u015f\u0131lm\u0131\u015ft\u0131r.<\/p>\n
Bu bilimsel bulgular sadece hastal\u0131k mekanizmalar\u0131n\u0131 anlamakla kalmay\u0131p, klinik tedavi ve \u00f6nleme stratejileri i\u00e7in de yeni ufuklar a\u00e7maktad\u0131r. IL-17A\u2019n\u0131n bloke edilmesi veya ILC3 h\u00fccrelerinin aktivitesinin mod\u00fcle edilmesi, invazif tarama ve cerrahi m\u00fcdahaleye dayal\u0131 mevcut y\u00f6ntemlere alternatif veya destekleyici yenilik\u00e7i tedaviler olarak \u00f6ne \u00e7\u0131kmaktad\u0131r. Kal\u0131tsal ileri derecede risk ta\u015f\u0131yan FAP hastalar\u0131nda ba\u011f\u0131\u015f\u0131kl\u0131k sistemi hedefli tedaviler geli\u015ftirmek, klinik y\u00f6netimde devrim niteli\u011finde bir yakla\u015f\u0131m olu\u015fturabilir. B\u00f6ylece hastalar hastal\u0131\u011f\u0131n ini\u015f \u00e7\u0131k\u0131\u015flar\u0131ndan korunabilir ve erken kanser geli\u015fimi engellenebilir.<\/p>\n
Bonn \u00dcniversitesi Hastanesi\u2019nden Do\u00e7. Dr. Benjamin Kr\u00e4mer, ayn\u0131 APC gen mutasyonuna sahip bireylerde hastal\u0131k seyrindeki farkl\u0131l\u0131klar\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131 ve lokal imm\u00fcn mikro\u00e7evre gibi ekstragenetik fakt\u00f6rlere ba\u011fl\u0131 oldu\u011funu vurgulamaktad\u0131r. Bu perspektif, kal\u0131tsal kanser predispozisyonlar\u0131n\u0131n ba\u011f\u0131\u015f\u0131k h\u00fccrelerle etkile\u015fimlerinin derinlemesine incelenmesini zorunlu k\u0131lmaktad\u0131r. Ara\u015ft\u0131rman\u0131n \u00f6zellikle do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerine odaklanmas\u0131, hastal\u0131k seyrinin belirsizli\u011fini azaltmak a\u00e7\u0131s\u0131ndan b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r.<\/p>\n
Ara\u015ft\u0131rman\u0131n farkl\u0131 disiplinlerden uzmanlar\u0131 bir araya getirmesi ba\u015far\u0131da kritik rol oynam\u0131\u015f, Bonn\u2019daki Alman N\u00f6rodejeneratif Hastal\u0131klar Merkezi (DZNE), Berlin\u2019deki Alman Romatizma Ara\u015ft\u0131rma Merkezi (DRFZ) ve M\u00fcnih Ludwig-Maximilians \u00dcniversitesi gibi prestijli kurumlar\u0131n katk\u0131lar\u0131yla b\u00f6ylesine kapsaml\u0131 ve b\u00fct\u00fcnsel bir \u00e7al\u0131\u015fma m\u00fcmk\u00fcn olmu\u015ftur. Bu \u00e7ok merkezli i\u015fbirli\u011fi, imm\u00fcnoloji, gastroenteroloji, molek\u00fcler biyoloji ve klinik onkoloji alanlar\u0131ndaki yenilik\u00e7i yakla\u015f\u0131mlarla birle\u015ftirilmi\u015ftir.<\/p>\n
FAP\u2019ya ba\u011fl\u0131 polip ve erken t\u00fcm\u00f6r \u00e7evresinde artan ILC3 h\u00fccre n\u00fcfusu, \u015fimdiye kadar g\u00f6zden ka\u00e7an inflamasyon-kanserle\u015fme eksenini g\u00f6zler \u00f6n\u00fcne sermi\u015ftir. National Center for Hereditary Tumor Diseases\u2019da k\u0131demli hekim Dr. Robert H\u00fcneburg, bu h\u00fccre infiltrasyonunun sadece pasif bir reaksiyon de\u011fil, oksidatif hasar\u0131 art\u0131rarak t\u00fcm\u00f6rle\u015fmeye katk\u0131 sa\u011flayan aktif bir mekanizma oldu\u011funu belirtmi\u015ftir.<\/p>\n
Prof. Dr. Jacob Nattermann ise IL-17A\u2019n\u0131n \u00f6zellikle duodenal mukozaya y\u00f6nelik spesifik blokaj\u0131n\u0131n, ROS kaynakl\u0131 DNA hasar\u0131n\u0131n kar\u015f\u0131l\u0131kl\u0131 \u00e7o\u011falma d\u00f6ng\u00fcs\u00fcn\u00fc bask\u0131layarak kanser olu\u015fum s\u00fcrecini yava\u015flatabilece\u011fine dikkat \u00e7ekmi\u015ftir. Bu yakla\u015f\u0131m, sistemik yan etkileri azaltan ve yaln\u0131zca hastal\u0131\u011f\u0131n lokalize oldu\u011fu b\u00f6lgede etkili olan bir imm\u00fcnoterapi paradigmas\u0131 yaratmaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rman\u0131n ilk yazar\u0131 Dr. Kim Melanie Kaiser, NKp44 negatif ILC3’lerin tan\u0131mlanmas\u0131n\u0131n mukozal imm\u00fcn biyolojide yeni bir d\u00f6nem ba\u015flatt\u0131\u011f\u0131n\u0131 belirtmi\u015f; bu do\u011fal lenfoid h\u00fccrelerin, adaptif imm\u00fcn h\u00fccreler taraf\u0131ndan g\u00f6lgede b\u0131rak\u0131lan ba\u011f\u0131\u015f\u0131kl\u0131k d\u00fczenleyici rolleri \u00f6zellikle IL-17A \u00fcretimi yoluyla dokuda hem DNA hasar\u0131n\u0131 hem de t\u00fcm\u00f6r\u00fcn di\u011fer biyolojik s\u00fcre\u00e7lerini \u015fekillendirebildi\u011fine dikkat \u00e7ekmi\u015ftir. Bu h\u00fccrelerin angiogenez ve stromal doku yeniden \u015fekillenmesinde de etkili olabilece\u011fi d\u00fc\u015f\u00fcn\u00fclmektedir.<\/p>\n
Klinik uygulamada, mevcut tarama ve cerrahi m\u00fcdahale y\u00f6ntemlerinin yan\u0131na imm\u00fcnolojik parametrelerin eklenmesi, duodenal neoplazi y\u00f6netiminde yeni bir \u00e7a\u011f\u0131n ba\u015flang\u0131c\u0131 olabilir. IL-17A inhibit\u00f6rleri veya ILC3 hedefli tedavilerin FAP hastalar\u0131nda erken kanser tespit ve \u00f6nlemede kullan\u0131lmaya ba\u015flanmas\u0131, hastalar\u0131n ya\u015fam kalitesini b\u00fcy\u00fck oranda art\u0131racak, hastal\u0131\u011f\u0131n seyrini de\u011fi\u015ftirebilecek \u00f6nemli bir ad\u0131md\u0131r.<\/p>\n
Sonu\u00e7 olarak, bu ara\u015ft\u0131rma, kal\u0131tsal genetik risk alt\u0131nda bulunan bir pop\u00fclasyonda i\u00e7sel ba\u011f\u0131\u015f\u0131kl\u0131k dengesizli\u011finin kanser geli\u015fimine nas\u0131l do\u011frudan katk\u0131 verdi\u011fini ortaya koyarken, IL-17A \u00fcreten ILC3 h\u00fccrelerini potansiyel tan\u0131 ve tedavi hedefleri olarak konumland\u0131rmaktad\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi d\u0131\u015fardan gelen tehditlere kar\u015f\u0131 koruyucu olsa da, bu t\u00fcr \u00f6zel i\u00e7 ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri arac\u0131l\u0131\u011f\u0131yla bazen malign mutasyonlar\u0131n h\u0131zland\u0131r\u0131c\u0131s\u0131 olabilmektedir. Bu bulgu, sadece FAP \u00f6zelinde de\u011fil, benzer iltihabi ve genetik mekanizmalar\u0131n i\u015fledi\u011fi di\u011fer kanser t\u00fcrleri i\u00e7in de yeni tedavi stratejilerinin geli\u015ftirilmesine ilham verecektir. Imm\u00fcnoloji ve onkoloji aras\u0131ndaki etkile\u015fimlerin derin mekanizmalar\u0131n\u0131n ayd\u0131nlat\u0131lmas\u0131, ya\u015fam kurtar\u0131c\u0131 yeniliklerin kap\u0131s\u0131n\u0131 aralamaktad\u0131r.<\/p>\n
— Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Haberin Yay\u0131n Tarihi<\/strong>: Web References<\/strong>: Doi Referans<\/strong>: Anahtar Kelimeler<\/strong>: Gastrointestinal onkoloji alan\u0131nda en zorlu kal\u0131tsal hastal\u0131klardan biri olarak kabul edilen Familial Adenomatous Polyposis (FAP), erken ya\u015fta kal\u0131n ba\u011f\u0131rsakta y\u00fczlerce hatta binlerce polip olu\u015fumuyla karakterize bir tablo sergilemektedir. Bu hastal\u0131\u011f\u0131n en kritik risk unsurlar\u0131 aras\u0131nda kolon kanseri geli\u015fimi yer al\u0131rken, son d\u00f6nemlerde yap\u0131lan ara\u015ft\u0131rmalar, duodenumda da kanser geli\u015fme riskinin olduk\u00e7a y\u00fcksek oldu\u011funu ortaya koymaktad\u0131r. Ancak,…<\/p>\n","protected":false},"author":1,"featured_media":3904,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[3286,3290,3287,3289,3288],"tmauthors":[],"class_list":{"0":"post-3903","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-duodenal-kanseri-koruma-yontemleri","9":"tag-duodenal-mukozada-inflamasyon-ve-kanser-gelisimi","10":"tag-familial-adenomatous-polyposis-ve-duodenal-kanser-riski","11":"tag-il-17a-ve-reaktif-oksijen-turleri-iliskisi","12":"tag-ilc3-hucrelerinin-duodenal-kanserde-rolu"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Duodenal-Kanserine-Yonelik-Yenilikci-Koruma-Yontemi-1745595016.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3903"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3904"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3903"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nAra\u015ft\u0131rma Konusu<\/strong>:
\nIL-17A \u00fcreten tip 3 do\u011fal lenfoid h\u00fccrelerin (ILC3) Familial Adenomatous Polyposis (FAP) hastalar\u0131n\u0131n duodenal dokusundaki birikiminin, duodenal kanser geli\u015fimindeki rol\u00fc.<\/p>\n
\nIL-17A-producing NKp44(-) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue.<\/p>\n
\n2024 (tahmini)<\/p>\n
\nhttp:\/\/dx.doi.org\/10.1038\/s41467-025-58907-y<\/p>\n
\nKim M. Kaiser et al., Nature Communications, DOI: 10.1038\/s41467-025-58907-y<\/p>\n
\nFamilial Adenomatous Polyposis, FAP, duodenal kanser, do\u011fal lenfoid h\u00fccreler, ILC3, interl\u00f6kin-17A, IL-17A, reaktif oksijen t\u00fcrleri, ROS, imm\u00fcnoloji, kanser \u00f6nleme, gastrointestinal onkoloji.<\/p>\n","protected":false},"excerpt":{"rendered":"